Towards engineering hormone-binding globulins as drug delivery agents.
The treatment of many diseases such as cancer requires the use of drugs that can cause severe side effects. Off-target toxicity can often be reduced simply by directing the drugs specifically to sites of diseases. Amidst increasingly sophisticated methods of targeted drug delivery, we observed that...
Saved in:
| Main Authors: | Wee Lee Chan, Aiwu Zhou, Randy J Read |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0113402 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sex-specific associations of sex hormone binding globulin and risk of bladder cancer
by: Ou Junyong, et al.
Published: (2025-02-01) -
Sex Hormone Binding Globulin Modifies Testosterone Action and Metabolism in Prostate Cancer Cells
by: Huika Li, et al.
Published: (2016-01-01) -
Mendelian randomization study reveals the causal effect of sex hormone binding globulin on osteoporosis
by: Guo-Si-Lang Zuo, et al.
Published: (2025-07-01) -
New Insights in the Diagnostic Potential of Sex Hormone-Binding Globulin (SHBG)—Clinical Approach
by: Weronika Szybiak-Skora, et al.
Published: (2025-05-01) -
Genetic Variants Linked with the Concentration of Sex Hormone-Binding Globulin Correlate with Uterine Fibroid Risk
by: Marina Ponomarenko, et al.
Published: (2025-07-01)